Sort
53,477 grants matching “addiction”
Drug Dependence Clinical Research Program-Research Support Core
$622,740Reese T. Jones · University Of California, San Francisco · P30 · FY2019 · DA
Identification of Genetic Variants that Contribute to Compulsive Cocaine Intake inRats
$622,683Olivier George · University Of California, San Diego · U01 · FY2019 · DA
A randomized trial of abandoned housing remediation, substance abuse and violence
$622,667John M Macdonald · University Of Pennsylvania · R01 · FY2019 · AA
Project 1 - Design and Synthesis of Novel Functionally Selective CB1 and CB2 Cannabinergic Ligands
$622,643Alexandros Makriyannis · Northeastern University · P01 · FY2023 · DA
Molecular and functional architecture of a premotor circuit for decision making
$622,618Zheng Herbert Wu · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · MH
Chemical biology of Peptide Regulation of Opioid Receptor Function
$622,592Carrie Haskell-Luevano · University Of Minnesota · R01 · FY2024 · DA
Topiramate-Phentermine Combinations for Cocaine Dependence
$622,578Craig R Rush · University Of Kentucky · R01 · FY2015 · DA
Adherence Monitoring for Substance Abuse Clinical Trials
$622,556Odile H Clavier · Creare, Llc · R44 · FY2014 · DA
Discovery of Bifunctional NOP/Opioid Receptor Ligands for Drug Abuse Therapy
$622,553Nurulain T Zaveri · Astraea Therapeutics, Llc · R01 · FY2009 · DA
Northeast Node of the National Drug Abuse Clinical Trials Network
$622,500Lisa A Marsch · Dartmouth College · UG1 · FY2020 · DA
Integrating Epigenomics in Human Brain and Genomics of Nicotine Dependence
$622,481Dana B Hancock · Research Triangle Institute · R01 · FY2020 · DA
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network
$622,479T John Winhusen · University Of Cincinnati · UG1 · FY2017 · DA
The Impact of Opioids on Health Outcomes for Hospitalized Infants
$622,441Lorraine I Kelley-Quon · Children'S Hospital Of Los Angeles · R01 · FY2023 · HD
Transition to Long-Term Opioid Use Among Older Adults with Chronic Pain
$622,417Michael R Von Korff · Kaiser Foundation Health Plan Of Washington · R01 · FY2011 · AG
Trajectories of Isolation and (A)Loneliness with AOD Use, 2019-2027: A National Egocentric Network Study of US Adults
$622,364Michael Sean Pollard · Rand Corporation · R01 · FY2025 · AA
Modeling and Predicting Therapeutic Resistance of Cancer
$622,359Dean W Felsher · Stanford University · U01 · FY2014 · CA
Development of a Cocaine-Metabolizing Enzyme for Drug Overdose Treatment
$622,350Chang-Guo Zhan · University Of Kentucky · R01 · FY2012 · DA
Gefitinib-sensitive EGF receptor mutants in lung cancer
$622,316Jeffrey E Settleman · Massachusetts General Hospital · R01 · FY2007 · CA
Evaluating the potential impact of a menthol ban in cigarettes and e-cigarettes among current menthol smokers
$622,295Krysten W. Bold · Yale University · R01 · FY2022 · DA
EXEMPLAR HOSPITAL INITIATION TRIAL TO ENHANCE TREATMENT ENGAGEMENT (CTN-0098). JUNE 10, 2024 TO NOVEMBER 1, 2026. N01DA-22-2253. TASK ORDER NO. 75N95024F00003 (TO19).
$622,266Jennifer McCormack · The Emmes Company, Llc · N01 · FY2024 · DA
PRACT: A Pragmatic Randomized Adaptive Clinical Trial to Investigate Controlling Alcohol related harms in a Low-Income Setting; Emergency Department Brief Interventions in Tanzania
$622,258Catherine Ann Staton · Duke University · R01 · FY2021 · AA
Developing nonmuscle II inhibitors for substance use relapse
$622,212Courtney A Miller · Scripps Florida · UH3 · FY2017 · NS
Use of Next-Gen Sequencing to Identify Genetic Variants that Influence compulsiveOxycodone Intake in Outbred Rats
$622,134Olivier George · University Of California, San Diego · U01 · FY2021 · DA
Novel Dopamine D3 Receptor Ligands
$622,131Amy Hauck Newman · National Institute On Drug Abuse · ZIA · FY2020 · DA
Early Exposure to Stimulants as a Risk Factor for Substance Abuse
$622,093Linda J. Porrino · Wake Forest University Health Sciences · R01 · FY2007 · DA